Cargando…
The Metabolism of Separase Inhibitor Sepin-1 in Human, Mouse, and Rat Liver Microsomes
Separase, a known oncogene, is widely overexpressed in numerous human tumors of breast, bone, brain, blood, and prostate. Separase is an emerging target for cancer therapy, and separase enzymatic inhibitors such as sepin-1 are currently being developed to treat separase-overexpressed tumors. Drug me...
Autores principales: | Li, Feng, Zhang, Nenggang, Gorantla, Siddharth, Gilbertson, Scott R., Pati, Debananda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949348/ https://www.ncbi.nlm.nih.gov/pubmed/29867452 http://dx.doi.org/10.3389/fphar.2018.00313 |
Ejemplares similares
-
Data set on Separase Inhibitor–Sepin-1 toxicity on organ weights, hematology and clinical parameters in Sprague-Dawley rats
por: Zhang, Nenggang, et al.
Publicado: (2020) -
Separase Inhibitor Sepin-1 Inhibits Foxm1 Expression and Breast Cancer Cell Growth
por: Zhang, Nenggang, et al.
Publicado: (2018) -
Separase Loss of Function Cooperates with the Loss of p53 in the Initiation and Progression of T- and B-Cell Lymphoma, Leukemia and Aneuploidy in Mice
por: Mukherjee, Malini, et al.
Publicado: (2011) -
Inhibitory mechanism of vortioxetine on CYP450 enzymes in human and rat liver microsomes
por: Zhan, Yunyun, et al.
Publicado: (2023) -
Evaluation of Herb–Drug Interaction Between Danshen and Rivaroxaban in Rat and Human Liver Microsomes
por: Wang, Xu, et al.
Publicado: (2022)